Skip Navigation LinksHome > August 2001 - Volume 24 - Issue 4 > Systemic Chemotherapy in Patients With Renal Failure
American Journal of Clinical Oncology:

Systemic Chemotherapy in Patients With Renal Failure

Bekele, Lishan B.A.; Vazquez, Marieberta Vidal B.S.; Adjei, Alex A. M.D., Ph.D.

Collapse Box


The administration of systemic chemotherapy to patients with moderate‐to‐severe organ impairment remains a challenge. In renal failure, guidelines for dose adjustments exist for very few chemotherapy agents. Subsequently, oncologists typically withhold treatment with systemic chemotherapy for patients with severe renal dysfunction. We present the case of a patient with metastatic transitional cell carcinoma of the bladder and renal failure who underwent successful systemic chemotherapy with paclitaxel and carboplatin. The data on systemic chemotherapy in patients with severe renal dysfunction are reviewed.

© 2001 Lippincott Williams & Wilkins, Inc.


Article Tools


Article Level Metrics

Search for Similar Articles
You may search for similar articles that contain these same keywords or you may modify the keyword list to augment your search.

Connect With Us


For additional oncology content, visit LWW Oncology Journals on Facebook.